Inflammation resolved by retinoid X receptor-mediated inactivation of leukotriene signaling pathways

FASEB Journal

Volumn 22, Issue 2, 2008, Pages 538-547

  Kalsotra, Auinash ^a   Du, Liping ^b   Wang, Ying ^a   Ladd, Patricia A ^b   Kikuta, Yasushi ^c   Duvic, Madeleine ^d   Boyd, Alan S ^b   Keeney, Diane S ^b   Strobel, Henry W ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c FUKUYAMA UNIVERSITY   (Japan)

^d University of Texas Health Science Center at Houston   (United States)

Author keywords

Cytochromes P450 4F; Epidermal inflammation; Resolution signals

Indexed keywords

LEUKOTRIENE B4; OXYGENASE; PROTEIN CYP4F; RETINOIC ACID; RETINOID X RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME REGULATION; EPIDERMIS CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELL DIFFERENTIATION; CELLS, CULTURED; CYTOCHROME P-450 ENZYME SYSTEM; EPIDERMIS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INFLAMMATION; LEUKOTRIENES; RETINOID X RECEPTORS; SIGNAL TRANSDUCTION; TRETINOIN; UP-REGULATION;

EID: 38949129688     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.07-9244com     Document Type: Article

References (64)

1. Gilroy, D. W., Lawrence, T., Perretti, M., and Rossi, A. G. (2004) Inflammatory resolution: new opportunities for drug discovery. Nat. Rev. Drug Discov. 3, 401-416
2. Smith, K. J., and Skelton, H. (2002) Arachidonic acid-derived bioactive lipids: their role and the role for their inhibitors in dermatology. J. Cutan. Med. Surg. 6, 241-256
3. Peters-Golden, M., Canetti, C., Mancuso, P., and Coffey, M. J. (2005) Leukotrienes: underappreciated mediators of innate immune responses. J. Immunol. 174, 589-594
4. Nathan, C. (2002) Points of control in inflammation. Nature 420, 846-852
5. Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., and Serhan, C. N. (2001) Lipid mediator class switching during acute inflammation: signals in resolution. Nat. Immunol. 2, 612-619
6. Kalsotra, A., and Strobel, H. W. (2006) Cytochrome P450 4F subfamily: At the crossroads of eicosanoid and drug metabolism. Pharmacol. Ther. 112, 589-611
7. Kikuta, Y., Kusunose, E., and Kusunose, M. (2002) Prostaglandin and leukotriene omega-hydroxylases. Prostag. Other Lipid Mediat. 68-69, 345-362
8. Cui, X., Kalsotra, A., Robida, A. M., Matzilevich, D., Moore, A. N., Boehme, C. L., Morgan, E. T., Dash, P. K., and Strobel, H. W. (2003) Expression of cytochromes P450 4F4 and 4F5 in infection and injury models of inflammation. Biochim. Biophys. Acta 1619, 325-331
9. Kalsotra, A., Cui, X., Antonovic, L., Robida, A. M., Morgan, E. T., and Strobel, H. W. (2003) Inflammatory prompts produce isoform-specific changes in the expression of leukotriene B(4) omega-hydroxylases in rat liver and kidney. FEBS Lett. 555, 236-242
10. Rizzo, W. B., and Carney, G. (2005) Sjogren-Larsson syndrome: diversity of mutations and polymorphisms in the fatty aldehyde dehydrogenase gene (ALDH3A2). Hum. Mutat. 26, 1-10
11. Salmon, J. K., Armstrong, C. A., and Ansel, J. C. (1994) The skin as an immune organ. West. J. Med. 160, 146-152
12. Barker, J. N., Mitra, R. S., Griffiths, C. E., Dixit, V. M., and Nickoloff, B. J. (1991) Keratinocytes as initiators of inflammation. Lancet 337, 211-214
13. Kupper, T. S. (1990) Immune and inflammatory processes in cutaneous tissues. Mechanisms and speculations. J. Clin. Invest. 86, 1783-1789
14. Kupper, T. S., and Fuhlbrigge, R. C. (2004) Immune surveillance in the skin: mechanisms and clinical consequences. Nat. Rev. Immunol. 4, 211-222
15. Steinhoff, M., Brzoska, T., and Luger, T. A. (2001) Keratinocytes in epidermal immune responses. Curr. Opin. Allergy Clin. Immunol. 1, 469-476
16. Ahmad, N., and Mukhtar, H. (2004) Cytochrome P450: a target for drug development for skin diseases. J. Invest. Dermatol. 123, 417-425
17. Du, L., Neis, M. M., Ladd, P. A., and Keeney, D. S. (2006) Differentiation-specific factors modulate epidermal CYP1-4 gene expression in human skin in response to retinoic acid and classical aryl hydrocarbon receptor ligands. J. Pharmacol. Exp. Ther. 319, 1162-1171
18. Merk, H. F., Abel, J., Baron, J. M., and Krutmann, J. (2004) Molecular pathways in dermatotoxicology. Toxicol. Appl. Pharmacol. 195, 267-277
19. Mukhtar, H., Bik, D. P., Ruzicka, T., Merk, H. F., and Bickers, D. R. (1989) Cytochrome P-450-dependent omega-oxidation of leukotriene B4 in rodent and human epidermis. J. Invest. Dermatol. 93, 231-235
20. Nelson, D. R., Zeldin, D. C., Hoffman, S. M. G., Maltais, L. J., Wain, H. M., and Nebert, D. W. (2004) Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics 14, 1-18
21. Stark, K., Schauer, L., Sahlen, G. E., Ronquist, G., and Oliw, E. H. (2004) Expression of CYP4F12 in gastrointestinal and urogenital epithelia. Basic Clin. Pharmacol. Toxicol. 94, 177-183
22. Stark, K., Torma, H., Cristea, M., and Oliw, E. H. (2003) Expression of CYP4F8 (prostaglandin H 19-hydroxylase) in human epithelia and prominent induction in epidermis of psoriatic lesions. Arch. Biochem. Biophys. 409, 188-196
23. Stark, K., Torma, H., and Oliw, E. H. (2006) Co-localization of COX-2, CYP4F8, and mPGES-1 in epidermis with prominent expression of CYP4F8 mRNA in psoriatic lesions. Prostag. Other Lipid Mediat. 79, 114-125
24. Stark, K., Wongsud, B., Burman, R., and Oliw, E. H. (2005) Oxygenation of polyunsaturated long chain fatty acids by recombinant CYP4F8 and CYP4F12 and catalytic importance of Tyr-125 and Gly-328 of CYP4F8. Arch. Biochem. Biophys. 441, 174-181
25. Sanders, R. J., Ofman, R., Duran, M., Kemp, S., and Wanders, R. J. (2006) Omega-oxidation of very long-chain fatty acids in human liver microsomes. Implications for X-linked adrenoleukodystrophy. J. Biol. Chem. 281, 13180-13187
26. Le Quere, V., Plee-Gautier, E., Potin, P., Madec, S., and Salaun, J. P. (2004) Human CYP4F3s are the main catalysts in the oxidation of fatty acid epoxides. J. Lipid Res. 45, 1446-1458
27. Sontag, T. J., and Parker, R. S. (2002) Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status. J. Biol. Chem. 277, 25290-25296
28. Xu, F., Ng, V. Y., Kroetz, D. L., and de Montellano, P. R. (2006) CYP4 isoform specificity in the omega-hydroxylation of phytanic acid, a potential route to elimination of the causative agent of Refsum's disease. J. Pharmacol. Exp. Ther. 318, 835-839
29. Du, L., Neis, M. M., Ladd, P. A., Lanza, D. L., Yost, G. S., and Keeney, D. S. (2006) Effects of the differentiated keratinocyte phenotype on expression levels of CYP1-4 family genes in human skin cells. Toxicol. Appl. Pharmacol. 213, 135-144
30. Kikuta, Y., Yamashita, Y., Kashiwagi, S., Tani, K., Okada, K., and Nakata, K. (2004) Expression and induction of CYP4F subfamily in human leukocytes and HL60 cells. Biochim. Biophys. Acta 1683, 7-15
31. Du, L., Yermalitsky, V., Hachey, D. L., Jagadeesh, S. G., Falck, J. R., and Keeney, D. S. (2006) A biosynthetic pathway generating 12-hydroxy-5,8,14- eicosatrienoic acid from arachidonic acid is active in mouse skin microsomes. J. Pharmacol. Exp. Ther. 316, 371-379
32. Kalsotra, A., Turman, C. M., Kikuta, Y., and Strobel, H. W. (2004) Expression and characterization of human cytochrome P450 4F11: Putative role in the metabolism of therapeutic drugs and eicosanoids. Toxicol. Appl. Pharmacol. 199, 295-304
33. Ladd, P. A., Du, L., Capdevila, J. H., Mernaugh, R., and Keeney, D. S. (2003) Epoxyeicosatrienoic acids activate transglutaminases in situ and induce cornification of epidermal keratinocytes. J. Biol. Chem. 278, 35184-35192
34. Heinemeyer, T., Wingender, E., Reuter, I., Hermjakob, H., Kel, A. E., Kel, O. V., Ignatieva, E. V., Ananko, E. A., Podkolodnaya, O. A., Kolpakov, F. A., Podkolodny, N. L., and Kolchanov, N. A. (1998) Databases on transcriptional regulation: TRANSFAC, TRRD, and COMPEL. Nucleic Acids Res. 26, 362-367
35. Honkakoski, P., and Negishi, M. (2000) Regulation of cytochrome P450 (CYP) genes by nuclear receptors. Biochem. J. 347, 321-337
36. Fisher, G. J., and Voorhees, J. J. (1996) Molecular mechanisms of retinoid actions in skin. FASEB J. 10, 1002-1013
37. Blomhoff, R., and Blomhoff, H. K. (2006) Overview of retinoid metabolism and function. J. Neurobiol. 66, 606-630
38. Duvic, M., Nagpal, S., Asano, A. T., and Chandraratna, R. A. (1997) Molecular mechanisms of tazarotene action in psoriasis. J. Am. Acad. Dermatol. 37, S18-24
39. Thacher, S. M., Vasudevan, J., and Chandraratna, R. A. (2000) Therapeutic applications for ligands of retinoid receptors. Curr. Pharm. Des. 6, 25-58
40. Winterfield, L., Cather, J., Cather, J., and Menter, A. (2003) Changing paradigms in dermatology: nuclear hormone receptors. Clin. Dermatol. 21, 447-454
41. Zouboulis, C. C. (2001) Retinoids - which dermatological indications will benefit in the near future? Skin. Pharmacol. Appl. Skin. Physiol. 14, 303-315
42. Kalsotra, A., Zhao, J., Anakk, S., Dash, P. K., and Strobel, H. W. (2007) Brain trauma leads to enhanced lung inflammation and injury: evidence for role of P4504Fs in resolution. J. Cereb. Blood. Flow. Metab. 27, 963-974
43. Kalsotra, A., Anakk, S., Brommer, C. L., Kikuta, Y., Morgan, E. T., and Strobel, H. W. (2007) Catalytic characterization and cytokine mediated regulation of cytochrome P450 4Fs in rat hepatocytes. Arch. Biochem. Biophys. 461, 104-112
44. Berry, K. A., Borgeat, P., Gosselin, J., Flamand, L., and Murphy, R. C. (2003) Urinary metabolites of leukotriene B4 in the human subject. J. Biol. Chem. 278, 24449-24460
45. Wheelan, P., Hankin, J. A., Bilir, B., Guenette, D., and Murphy, R. C. (1999) Metabolic transformations of leukotriene B4 in primary cultures of human hepatocytes. J. Pharmacol. Exp. Ther. 288, 326-334
46. Yokomizo, T., Izumi, T., and Shimizu, T. (2001) Leukotriene B4: metabolism and signal transduction. Arch. Biochem. Biophys. 385, 231-241
47. Wang, S., Gustafson, E., Pang, L., Qiao, X., Behan, J., Maguire, M., Bayne, M., and Laz, T. (2000) A novel hepatointestinal leukotriene B4 receptor. Cloning and functional characterization. J. Biol. Chem. 275, 40686-40694
48. Yokomizo, T., Kato, K., Hagiya, H., Izumi, T., and Shimizu, T. (2001) Hydroxyeicosanoids bind to and activate the low affinity leukotriene B4 receptor, BLT2. J. Biol. Chem. 276, 12454-12459
49. Soberman, R. J., Sutyak, J. P., Okita, R. T., Wendelborn, D. F., Roberts, L. J., 2nd, and Austen, K. F. (1988) The identification and formation of 20-aldehyde leukotriene B4. J. Biol. Chem. 263, 7996-8002
50. Murphy, R. C., and Gijon, M. A. (2007) Biosynthesis and metabolism of leukotrienes. Biochem. J. 405, 379-395
51. Christmas, P., Jones, J. P., Patten, C. J., Rock, D. A., Zheng, Y., Cheng, S. M., Weber, B. M., Carlesso, N., Scadden, D. T., Rettie, A. E., and Soberman, R. J. (2001) Alternative splicing determines the function of CYP4F3 by switching substrate specificity. J. Biol. Chem. 276, 38166-38172
52. Wheelan, P., Zirrolli, J. A., Morelli, J. G., and Murphy, R. C. (1993) Metabolism of leukotriene B4 by cultured human keratinocytes. Formation of glutathione conjugates and dihydro metabolites. J. Biol. Chem. 268, 25439-25448
53. Zhang, X., and Hardwick, J. P. (2000) Regulation of CYP4F2 leukotriene B4 omega-hydroxylase by retinoic acids in HepG2 cells. Biochem. Biophys. Res. Commun. 279, 864-871
54. Quack, M., Frank, C., and Carlberg, C. (2002) Differential nuclear receptor signalling from DR4-type response elements. J. Cell. Biochem. 86, 601-612
55. Baron, J. M., Heise, R., Blaner, W. S., Neis, M., Joussen, S., Dreuw, A., Marquardt, Y., Saurat, J. H., Merk, H. F., Bickers, D. R., and Jugert, F. K. (2005) Retinoic acid and its 4-oxo metabolites are functionally active in human skin cells in vitro. J. Invest. Dermatol. 125, 143-153
56. Heise, R., Mey, J., Neis, M. M., Marquardt, Y., Joussen, S., Ott, H., Wiederholt, T., Kurschat, P., Megahed, M., Bickers, D. R., Merk, H. F., and Baron, J. M. (2006) Skin retinoid concentrations are modulated by CYP26AI expression restricted to basal keratinocytes in normal human skin and differentiated 3D skin models. J. Invest. Dermatol. 126, 2473-2480
57. Fogh, K., and Kragballe, K. (2000) Eicosanoids in inflammatory skin diseases. Prostag. Other Lipid Mediat. 63, 43-54
58. Nigam, S., and Zafiriou, M. P. (2005) Hepoxilin A3 synthase. Biochem. Biophys. Res. Commun. 338, 161-168
59. Lefevre, C., Bouadjar, B., Ferrand, V., Tadini, G., Megarbane, A., Lathrop, M., Prud'homme, J. F., and Fischer, J. (2006) Mutations in a new cytochrome P450 gene in lamellar ichthyosis type 3. Hum. Mol. Genet. 15, 767-776
60. Arita, M., Clish, C. B., and Serhan, C. N. (2005) The contributions of aspirin and microbial oxygenase to the biosynthesis of anti-inflammatory resolvins: novel oxygenase products from omega-3 polyunsaturated fatty acids. Biochem. Biophys. Res. Commun. 338, 149-157
61. Arita, M., Bianchini, F., Aliberti, J., Sher, A., Chiang, N., Hong, S., Yang, R., Petasis, N. A., and Serhan, C. N. (2005) Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J. Exp. Med. 201, 713-722
62. Serhan, C. N., Clish, C. B., Brannon, J., Colgan, S. P., Chiang, N., and Gronert, K. (2000) Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J. Exp. Med. 192, 1197-1204
63. Curley, C. R., Monsuur, A. J., Wapenaar, M. C., Rioux, J. D., and Wijmenga, C. (2006) A functional candidate screen for coeliac disease genes. Eur. J. Hum. Genet. 14, 1215-1222
64. Talas, U., Dunlop, J., Khalaf, S., Leigh, I. M., and Kelsell, D. P. (2000) Human elastase 1: evidence for expression in the skin and the identification of a frequent frameshift polymorphism. J. Invest. Dermatol. 114, 165-170